This Is What You Need To Know About Human Genome Editing

0216CW_Feature_CRISPR_F5_630m

Scientists in the UK have been given a licence to edit the genes of human embryos. A team at the Francis Crick Institute, led by the embryologist Dr Kathy Niakan, applied for the license in September. Now, the Human Fertilisation and Authority (HFEA) has granted the team’s request.

However, this doesn’t mean that the research can now go ahead. There is another hurdle – ethical approval of the study itself. But the granting of a licence is a key step. The team will use a new genetic modification technique called CRISPR, which allows very specific edits to be made to genomes.

They hope that by removing genes from, or adding them to, the early embryo, they will be able to learn more about how healthy embryos develop. The research could help develop treatments for infertility. It could also help research into stem cells, which could lead to other medical breakthroughs.

READ THE REST HERE

About Peter Coffaro 1136 Articles

A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


*